The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...

Columnist Kristin Neva sometimes get overwhelmed by her increasing caregiver responsibilities, but it helps her to know she's not alone.

Kadimastem, the developer of the experimental amyotrophic lateral sclerosis (ALS) therapy AstroRx, is merging with NLS ...

Mitochondrial genome mutations may be linked to ALS, per a study, opening the door for new ways to diagnosing and treating ...

This November, the nonprofit I AM ALS is launching a peer support program as part of its new campaign focused on supporting ...

Auttx has received a grant from the ALS Network to advance research on treatments for ALS that could restore normal RNA ...

The funding will help support the Ontario Provincial ALS Program to meet the needs of the roughly 1,300 people in Ontario ...

Altered activity of ancient viral genes were linked to neurodegenerative diseases including ALS in a recent analysis.

Leal Therapeutics raised $45 million for drug development, including advancing a promising therapy into clinical trials for ...

Avicenna Biosciences has received its first patent covering new ROCK inhibitor compounds that may be used to treat ...

Long-term treatment with the cell therapy NurOwn was found to significantly extend survival for ALS patients compared with ...